39th National Symposium
ANNA 2008 Satellite Symposium
New Perspectives on the Progression of Coronary Artery Calcification
and Patient Outcomes in Chronic Kidney Disease

Phosphate Binders and Cardiovascular Calcification: Impact on Outcome of CKD Patients
Wajeh Qunibi, MD, FACP

Trials, tribulations, and observational data: How do we apply the data to our practice?
Lynda Szczech, MD, MSCE

  
At the conclusion of the certified activity, participants should be able to do the following:
Discuss the epidemiology of hyperphosphatemia and cardiovascular calcification in patients with stage 5 chronic kidney disease (CKD)
Interpret the salient findings from recent clinical trials that investigated cardiovascular progression and mortality rates among patients with stage 5 CKD who were treated with various phosphate binders
Apply the process for the development of evidence-based best practices aimed at improving the quality of care for patients with stage 5 CKD.

Wajeh Qunibi, MD, FACP
Professor of Medicine
Medical Director of Dialysis Services
University of Texas Health Science Center
San Antonio, TX

Lynda Szczech, MD, MSCE
Associate Professor of Medicine
Duke University Medical Center
This activity has been planned and produced in accordance with CE guidelines and policies. From a CE symposium held in April 2008 at the American Nephrology Nurses' Association (ANNA) Annual Meeting in Philadelphia, PA.

This activity provides 1.5 contact hours.

The American Nephrology Nurses’ Association (ANNA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910 for 1.5 contact hours.

Posting Date: August 12, 2008
CE Credit Eligible Through: August 12, 2010
CE Credit Hours/Completion Time: 1.5
Target Audiences: Nurses, nurse practitioners, and technicians.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the linked abstracts in the post-test answer feedback material.
 
SPEAKER DISCLOSURE STATEMENT:
See individual talks.

SPONSORSHIP / SUPPORT :
This ANNA Satellite symposium was suppored by an unrestricted educational grant from Fresenius Medical Care, Inc.

ANNA and HDCN CE POLICY STATEMENTS:
The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.
BACK TO
TOPIC INDEX :